CVN424 75 mg

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

CVN424 75 mg
Treatment and conditionWhere it standsTrials
CVN424 75 mg for parkinson diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1